Gastric adenocarcinoma treated with total gastrectomy in a man with CTLA4 insufficiency

This gastric cancer diagnosis at a glance

Subtype
Adenocarcinoma
Biomarkers
CTLA4 mutation
Sex
male
Treatment
surgery
Outcome
In Memory

Treatment course, step by step

  1. Total gastrectomy was performed at age 34.
  2. No perioperative chemotherapy was given.
  3. Follow-up gastroscopies were used to monitor for recurrent cancer.

What happened, in summary

A man with CTLA4 insufficiency had experienced chronic diarrhea since childhood and was later diagnosed with common variable immunodeficiency. Recurrent gastritis led to repeated endoscopies. At age 34, multiple gastric biopsies showed both poorly differentiated adenocarcinoma and well-differentiated tubular adenocarcinoma. No metastasis was found at that time.

He underwent total gastrectomy without perioperative chemotherapy. The operation treated the gastric cancer, but his underlying intestinal and immune problems remained severe. Prolonged diarrhea and enterocolitis continued for months after surgery despite immunosuppressive treatment.

Gastroscopy was used during follow-up to monitor for recurrent cancer. He never fully recovered from his broader medical problems. Twenty-five months after the gastrectomy, he developed Klebsiella pneumonia infection with sepsis and died.

He died from infection-related sepsis 25 months after the gastric surgery.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar gastric cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more gastric cancer stories